Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis.

PubWeight™: 2.92‹?› | Rank: Top 1%

🔗 View Article (PMC 3260875)

Published in J Exp Med on January 02, 2012

Authors

Florian Leuschner1, Philipp J Rauch, Takuya Ueno, Rostic Gorbatov, Brett Marinelli, Won Woo Lee, Partha Dutta, Ying Wei, Clinton Robbins, Yoshiko Iwamoto, Brena Sena, Aleksey Chudnovskiy, Peter Panizzi, Edmund Keliher, John M Higgins, Peter Libby, Michael A Moskowitz, Mikael J Pittet, Filip K Swirski, Ralph Weissleder, Matthias Nahrendorf

Author Affiliations

1: Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Simches Research Building, Boston, MA 02114, USA.

Articles citing this

(truncated to the top 100)

Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity (2012) 6.18

Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48

Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14

Tissue-resident macrophages. Nat Immunol (2013) 4.09

Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation. Immunity (2014) 3.54

Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science (2013) 3.22

Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci Transl Med (2014) 2.02

Macrophages are required for neonatal heart regeneration. J Clin Invest (2014) 1.93

Angiotensin II drives the production of tumor-promoting macrophages. Immunity (2013) 1.88

Origin of monocytes and macrophages in a committed progenitor. Nat Immunol (2013) 1.84

Monocyte subset accumulation in the human heart following acute myocardial infarction and the role of the spleen as monocyte reservoir. Eur Heart J (2013) 1.83

Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ Res (2014) 1.78

An abundant tissue macrophage population in the adult murine heart with a distinct alternatively-activated macrophage profile. PLoS One (2012) 1.76

Monocyte and macrophage heterogeneity in the heart. Circ Res (2013) 1.63

Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function. J Mol Cell Cardiol (2015) 1.54

Structure and function of renal macrophages and dendritic cells from lupus-prone mice. Arthritis Rheumatol (2014) 1.54

Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ Res (2014) 1.52

B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction. Nat Med (2013) 1.43

Splenocytes seed bone marrow of myeloablated mice: implication for atherosclerosis. PLoS One (2015) 1.40

The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth. BMC Cancer (2016) 1.39

The spleen in local and systemic regulation of immunity. Immunity (2013) 1.33

Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation (2013) 1.30

The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ Res (2016) 1.27

Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages. Exp Mol Med (2014) 1.26

Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc Res (2014) 1.21

Local apoptosis mediates clearance of macrophages from resolving inflammation in mice. Blood (2013) 1.12

Inflammatory monocytes and the pathogenesis of viral encephalitis. J Neuroinflammation (2012) 1.08

Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior. Front Neurosci (2015) 1.08

Macrophages retain hematopoietic stem cells in the spleen via VCAM-1. J Exp Med (2015) 1.06

Monocyte heterogeneity in cardiovascular disease. Semin Immunopathol (2013) 1.05

Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure. Circ Res (2016) 0.99

Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum". J Am Coll Cardiol (2016) 0.97

Myocardial Infarction Activates CCR2(+) Hematopoietic Stem and Progenitor Cells. Cell Stem Cell (2015) 0.96

Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes. Proc Natl Acad Sci U S A (2014) 0.95

Targeting Interleukin-1β Reduces Leukocyte Production After Acute Myocardial Infarction. Circulation (2015) 0.94

Peripheral and central effects of repeated social defeat stress: monocyte trafficking, microglial activation, and anxiety. Neuroscience (2015) 0.94

Myocardial infarction: a critical role of macrophages in cardiac remodeling. Front Physiol (2015) 0.94

From proliferation to proliferation: monocyte lineage comes full circle. Semin Immunopathol (2014) 0.93

Systemic inflammatory response following acute myocardial infarction. J Geriatr Cardiol (2015) 0.93

Making a difference: monocyte heterogeneity in cardiovascular disease. Curr Atheroscler Rep (2012) 0.93

Monocyte and macrophage contributions to cardiac remodeling. J Mol Cell Cardiol (2015) 0.93

Edible blue-green algae reduce the production of pro-inflammatory cytokines by inhibiting NF-κB pathway in macrophages and splenocytes. Biochim Biophys Acta (2013) 0.93

Immune surveillance of the central nervous system in multiple sclerosis--relevance for therapy and experimental models. J Neuroimmunol (2014) 0.93

Advancing biomedical imaging. Proc Natl Acad Sci U S A (2015) 0.91

Macrophage heterogeneity in the context of rheumatoid arthritis. Nat Rev Rheumatol (2016) 0.91

Beyond vascular inflammation--recent advances in understanding atherosclerosis. Cell Mol Life Sci (2015) 0.90

Noradrenergic neurons regulate monocyte trafficking and mortality during gram-negative peritonitis in mice. J Immunol (2013) 0.89

Stromal cells of the mouse spleen. Front Immunol (2012) 0.88

Origin, development, and homeostasis of tissue-resident macrophages. Immunol Rev (2014) 0.88

Acute myocardial infarction activates distinct inflammation and proliferation pathways in circulating monocytes, prior to recruitment, and identified through conserved transcriptional responses in mice and humans. Eur Heart J (2015) 0.87

The innate immune system after ischemic injury: lessons to be learned from the heart and brain. JAMA Neurol (2014) 0.87

The impact of Ly6Clow monocytes after cerebral hypoxia-ischemia in adult mice. J Cereb Blood Flow Metab (2014) 0.87

18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med (2014) 0.87

The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair. Int J Mol Sci (2013) 0.87

Magnetic resonance imaging investigation of macrophages in acute cardiac allograft rejection after heart transplantation. Circ Cardiovasc Imaging (2013) 0.86

Surgical manipulation compromises leukocyte mobilization responses and inflammation after experimental cerebral ischemia in mice. Front Neurosci (2014) 0.86

IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms. EMBO Mol Med (2014) 0.85

CD13 is essential for inflammatory trafficking and infarct healing following permanent coronary artery occlusion in mice. Cardiovasc Res (2013) 0.85

Disordered haematopoiesis and athero-thrombosis. Eur Heart J (2016) 0.85

Imaging systemic inflammatory networks in ischemic heart disease. J Am Coll Cardiol (2015) 0.84

Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts. Circ Cardiovasc Imaging (2013) 0.84

Communication in the heart: the role of the innate immune system in coordinating cellular responses to ischemic injury. J Cardiovasc Transl Res (2012) 0.84

Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure. Circ Heart Fail (2017) 0.84

Lifestyle effects on hematopoiesis and atherosclerosis. Circ Res (2015) 0.83

Spatially localized recruitment of anti-inflammatory monocytes by SDF-1α-releasing hydrogels enhances microvascular network remodeling. Biomaterials (2015) 0.83

Cells and iron oxide nanoparticles on the move: magnetic resonance imaging of monocyte homing and myocardial inflammation in patients with ST-elevation myocardial infarction. Circ Cardiovasc Imaging (2012) 0.82

Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction. Aging (Albany NY) (2016) 0.82

CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury. EMBO Mol Med (2014) 0.81

Innate immune cells in ischaemic heart disease: does myocardial infarction beget myocardial infarction? Eur Heart J (2015) 0.81

Cardiology: Bad matters made worse. Nature (2012) 0.81

The journey from stem cell to macrophage. Ann N Y Acad Sci (2014) 0.81

Sham surgery and inter-individual heterogeneity are major determinants of monocyte subset kinetics in a mouse model of myocardial infarction. PLoS One (2014) 0.81

Monocytes in sterile inflammation: recruitment and functional consequences. Arch Immunol Ther Exp (Warsz) (2013) 0.80

Phagocyte-myocyte interactions and consequences during hypoxic wound healing. Cell Immunol (2014) 0.80

Regulation and consequences of monocytosis. Immunol Rev (2014) 0.79

Control of dichotomic innate and adaptive immune responses by artery tertiary lymphoid organs in atherosclerosis. Front Physiol (2012) 0.79

Imaging macrophage development and fate in atherosclerosis and myocardial infarction. Immunol Cell Biol (2012) 0.79

Immunosenescence in monocytes, macrophages, and dendritic cells: lessons learned from the lung and heart. Immunol Lett (2014) 0.79

CXCR4 identifies transitional bone marrow premonocytes that replenish the mature monocyte pool for peripheral responses. J Exp Med (2016) 0.79

Multimodal iron oxide nanoparticles for hybrid biomedical imaging. NMR Biomed (2012) 0.78

Assessment of Myocardial Remodeling Using an Elastin/Tropoelastin Specific Agent with High Field Magnetic Resonance Imaging (MRI). J Am Heart Assoc (2015) 0.77

Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition. Hypertens Res (2015) 0.77

PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation. J Exp Med (2016) 0.77

Endoplasmic reticulum stress-dependent activation of ATF3 mediates the late phase of ischemic preconditioning. J Mol Cell Cardiol (2014) 0.77

Cardiac-Restricted IGF-1Ea Overexpression Reduces the Early Accumulation of Inflammatory Myeloid Cells and Mediates Expression of Extracellular Matrix Remodelling Genes after Myocardial Infarction. Mediators Inflamm (2015) 0.76

MMP-9 signaling in the left ventricle following myocardial infarction. Am J Physiol Heart Circ Physiol (2016) 0.76

Arterial Hypertension Aggravates Innate Immune Responses after Experimental Stroke. Front Cell Neurosci (2015) 0.76

It takes two to tango: monocyte and macrophage duality in the infarcted heart. Circ Res (2014) 0.76

Regulating repair: regulatory T cells in myocardial infarction. Circ Res (2014) 0.76

Knowledge gaps to understanding cardiac macrophage polarization following myocardial infarction. Biochim Biophys Acta (2016) 0.76

Blinding the monocytes to protect the heart. Circulation (2013) 0.76

Inflammation - Cause or Consequence of Heart Failure or Both? Curr Heart Fail Rep (2017) 0.76

E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction. Arterioscler Thromb Vasc Biol (2016) 0.75

Stroke: long-term effect of infections after stroke. Nat Rev Neurol (2013) 0.75

Cardiac inflammation in genetic dilated cardiomyopathy caused by MYBPC3 mutation. J Mol Cell Cardiol (2016) 0.75

Targeting splenic hematopoietic stem cells in cardiovascular disease. Oncotarget (2015) 0.75

Multiparametric Imaging of Organ System Interfaces. Circ Cardiovasc Imaging (2017) 0.75

Role of splenic reservoir monocytes in pulmonary vascular monocyte accumulation in experimental hepatopulmonary syndrome. J Gastroenterol Hepatol (2016) 0.75

Monocytes and macrophages in cardiac injury and repair. J Thorac Dis (2017) 0.75

Chemokines and Heart Disease: A Network Connecting Cardiovascular Biology to Immune and Autonomic Nervous Systems. Mediators Inflamm (2016) 0.75

Articles cited by this

Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07

Inflammation in atherosclerosis. Nature (2002) 28.92

Monocyte and macrophage heterogeneity. Nat Rev Immunol (2005) 24.36

Induction of apoptosis in fibroblasts by c-myc protein. Cell (1992) 16.95

The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96

Development of monocytes, macrophages, and dendritic cells. Science (2010) 12.86

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51

Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol (2006) 11.06

Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47

Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science (2007) 9.54

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09

The inflammatory response in myocardial infarction. Cardiovasc Res (2002) 7.92

Features of apoptotic cells measured by flow cytometry. Cytometry (1992) 6.45

In vivo analysis of dendritic cell development and homeostasis. Science (2009) 6.42

The science of stroke: mechanisms in search of treatments. Neuron (2010) 6.14

A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science (2005) 5.88

Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas. Cell (2010) 5.28

Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol (2005) 5.19

Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc Natl Acad Sci U S A (2004) 3.85

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85

Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest (2006) 3.77

Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J Am Coll Cardiol (2009) 3.44

Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery. J Exp Med (2006) 3.43

Myocyte death in the failing human heart is gender dependent. Circ Res (1999) 3.38

Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation (2010) 3.37

Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J Am Coll Cardiol (2002) 3.27

Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A (1983) 3.14

CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation. J Exp Med (2009) 3.07

Current concepts: immunology. Monocytes and macrophages. N Engl J Med (1988) 2.92

Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J Am Coll Cardiol (2010) 2.90

Changing face of microglia. Science (2010) 2.79

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct. Circ Res (2007) 2.77

Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab (2007) 2.31

Hybrid PET-optical imaging using targeted probes. Proc Natl Acad Sci U S A (2010) 2.17

Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler Thromb Vasc Biol (2009) 2.15

Measuring and modeling apoptosis in single cells. Cell (2011) 2.10

Origin and functional heterogeneity of non-lymphoid tissue dendritic cells in mice. Immunol Rev (2010) 1.99

Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res (2000) 1.84

Multimodality cardiovascular molecular imaging, Part II. Circ Cardiovasc Imaging (2009) 1.82

Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ Res (2010) 1.82

18F labeled nanoparticles for in vivo PET-CT imaging. Bioconjug Chem (2009) 1.78

Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ Res (1998) 1.78

Elevated peripheral blood mononuclear cell count is an independent predictor of left ventricular remodeling in patients with acute myocardial infarction. J Cardiol (2010) 1.59

The multiple roles of monocyte subsets in steady state and inflammation. Cell Mol Life Sci (2010) 1.50

Pravastatin improves remodeling and cardiac function after myocardial infarction by an antiinflammatory mechanism rather than by the induction of angiogenesis. Ann Thorac Surg (2006) 1.49

Myeloperoxidase-rich Ly-6C+ myeloid cells infiltrate allografts and contribute to an imaging signature of organ rejection in mice. J Clin Invest (2010) 1.48

The in vivo quantitation and kinetics of monocyte migration into acute inflammatory tissue. Am J Pathol (1981) 1.42

Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Blood (1993) 1.29

Cytokine receptor expression on hematopoietic stem and progenitor cells. Blood (1997) 1.20

Circulating interleukin-1 beta, interleukin-6, tumor necrosis factor-alpha, and soluble ICAM-1 in patients with chronic stable angina and myocardial infarction. Angiology (2001) 0.92

CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease. PLoS One (2011) 0.90

Interleukin-1 regulates hematopoietic progenitor and stem cells in the midgestation mouse fetal liver. Haematologica (2009) 0.86

Articles by these authors

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36

Detecting recent positive selection in the human genome from haplotype structure. Nature (2002) 22.00

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers. Nat Med (2008) 14.47

Restoration of p53 function leads to tumour regression in vivo. Nature (2007) 12.62

Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat Chem Biol (2005) 11.63

The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med (2007) 11.51

Imaging in the era of molecular oncology. Nature (2008) 11.10

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52

Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science (2009) 10.47

The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol (2006) 9.61

Looking and listening to light: the evolution of whole-body photonic imaging. Nat Biotechnol (2005) 9.57

Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA (2006) 9.27

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med (2003) 9.09

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA (2002) 8.81

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest (2007) 8.65

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation (2003) 8.61

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36

Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci (2003) 6.53

Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA (2004) 6.28

Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med (2014) 6.12

Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol (2002) 6.06

Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther (2005) 6.04

Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A (2006) 5.90

Fluorescence molecular tomography resolves protease activity in vivo. Nat Med (2002) 5.53

The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies. Cancer Cell (2006) 5.34

Arthritis critically dependent on innate immune system players. Immunity (2002) 5.31

Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11

The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell (2010) 5.11

Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med (2002) 4.86

Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc Natl Acad Sci U S A (2005) 4.63

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60

Myocardial infarction accelerates atherosclerosis. Nature (2012) 4.48

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46

A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med (2009) 4.46

Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med (2008) 4.29

Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo. Circulation (2007) 4.20

The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol (2008) 4.20

Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med (2013) 4.14

Magnetic relaxation switches capable of sensing molecular interactions. Nat Biotechnol (2002) 4.13

Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A (2004) 4.12

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med (2012) 4.11

Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem (2008) 4.08

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07

Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice. Nat Med (2009) 3.97

A spatially and temporally restricted mouse model of soft tissue sarcoma. Nat Med (2007) 3.96

Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. Circulation (2003) 3.94

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J (2011) 3.93

Tetrazine-based cycloadditions: application to pretargeted live cell imaging. Bioconjug Chem (2008) 3.93

Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity (2006) 3.92

Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis. Circulation (2007) 3.85

Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res (2002) 3.69

Fast and sensitive pretargeted labeling of cancer cells through a tetrazine/trans-cyclooctene cycloaddition. Angew Chem Int Ed Engl (2009) 3.63

Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation (2006) 3.57

Effect of two intensive statin regimens on progression of coronary disease. N Engl J Med (2011) 3.52

Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation (2007) 3.51

Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res (2008) 3.47

Molecular imaging in drug discovery and development. Nat Rev Drug Discov (2003) 3.44